Smith & Nephew plc (SN.) Ordinary USD0.20

Sell:1,033.00pBuy:1,034.00p16.00p (1.57%)

FTSE techMARK 100:0.68%
Market closed | Prices delayed by at least 15 minutes
Sell:1,033.00p
Buy:1,034.00p
Change:16.00p (1.57%)
Deal now
Market closed | Prices delayed by at least 15 minutes
Sell:1,033.00p
Buy:1,034.00p
Change:16.00p (1.57%)
Market closed | Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

Key people

Deepak S. Nath
Chief Executive Officer, Executive Director
John Rogers
Chief Financial Officer, Executive Director
Paul Connolly
President - Global Operations
Craig Gaffin
President - Orthopaedics
Rohit Kashyap
President - Advanced Wound Management and Global Commercial Operations
Vasant Padmanabhan
President - Research and Development
Scott Schaffner
President - Sports Medicine
Elga Lohler
Chief Human Resource Officer
Alison Parkes
Chief Compliance Officer
Helen Barraclough
Group General Counsel, Company Secretary
Rupert Christopher Soames
Non-Executive Independent Chairman of the Board
Erik Engstrom
Non-Executive Independent Director
Jo Hallas
Non-Executive Independent Director
Simon Jonathan Lowth
Non-Executive Independent Director
John Ma
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    SN.
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    GB0009223206
  • Market cap
    £9.01bn
  • Employees
    18,000
  • Shares in issue
    877.73m
  • Exchange
    London Stock Exchange (LON)
  • Index
    FTSE All Share Index, FTSE 100 Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.